ERNA vs LMT · P/E 0.0, rev $582.0K vs P/E 20, rev $75.05B
Eterna Therapeutics Inc (ERNA) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the ERNA and LMT stock pages for the full models.
Not investment advice.